Newest Issue is Out. Get your exclusive copy today.
TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.
Eli Lilly and Company discovered Retevmo™ (selpercatinib, 40 mg & 80 mg capsules) to treat patients with different types of cancers such as non-small cell lung cancer, medullary thyroid cancer and other types of thyroid cancer....
Sunovion Pharmaceuticals Inc launched a novel drug KYNMOBI™ (apomorphine HCI) sublingual film (APL-130277) for the acute and intermittent treatment of off episodes in patients with Parkinson’s disease....
ArcherDX, Inc has discovered a new next-generation sequencing (NGS) device to detect Neurotrophic Receptor Tyrosine Kinase (NTRK) gene fusions that leads to the formation and growth of cancer....
Deciphera Pharmaceuticals developed QINLOCK™ (ripretinib) 50mg capsules to treat adult patients with advanced gastrointestinal stromal tumour (GIST) who underwent prior treatment with three or more kinase inhibitors, including imatinib....
The researchers at the University of Louisville have discovered a technology for their research in fighting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)responsible for the COVID-19 pandemic....
Acceleron Pharma has discovered a novel investigational agent ‘sotatercept’ for the treatment of patients with Pulmonary Arterial Hypertension (PAH)....
SCIEX has launched an exciting new and innovative capillary electrophoretic method for streamlining and improving the production of gene therapies....
A novel 4D printing technique has been discovered by the Researchers at the Advanced Science Research Center at The Graduate Center, CUNY (CUNY ASRC), and Northwestern University...
Plasmology4® has developed a revolutionary, advanced, and specialised form of ‘non-thermal’ or ‘cold plasma’technology called ‘Plaz4®’....
Merck and the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia, have confirmed their findings of a novel class of candidate antimalarial agents that blocks the multiple stages of the malaria parasite’s lifecycle that causes the disease....
A new breakthrough has been discovered by the researchers from Trinity College Dublin, for people living with asthmathat may eventually lead to improved therapeutic options. An important role in defending against bacteria is played by Caspase-11. However, it has never been implicated in this disease before....
A microfluidic device has been created by a team of researchers led by the University of California San Diego which measures how ‘sticky’ cancer cells are and how they could improve prognostic evaluation of patient tumors....
A new drug, apabetalone in combination with the top standard of care, including high-intensity statins, has been launched by Resverlogix. The treatment was intended for the secondary prevention of Major Adverse Cardiac Events (MACE) in patients with type 2 diabetes mellitus and recent acute coronary syndrome....
A team of researchers from the Tokyo University of Science and other institutes have developed a first-of-its-kind cancer treatment strategy that targets a pro-tumor protein ‘FROUNT’ and suppresses Tumor-Associated Macrophages (TAMs)....
Aprea Therapeutics has launched a mutant p53 reactivating compound APR-246 in combination with chemotherapy drug azacitidine for the treatment of Myelodysplastic Syndromes (MDS) in patients having a susceptible TP53 mutation....
A new potential target for treating drug addiction through astrocytes, which the researchers from the University of Minnesota Medical School refer to ‘the hidden stars of the brain’, has been discovered....
A Personalized Cancer Monitoring (PCM) technology designed for minimally invasive monitoring and recurrence surveillance for early-stage cancer has been launched by ArcherDX....
A safer and more effective anticancer drug has been discovered by researchers from the University of Florida College of Pharmacy. The new treatment would target leukemia, lymphoma, and breast and lung cancers....
A new treatment and an industrial fabrication process called coaxial electrospinning have been developed by the researchers at the University of Cincinnati for the treatment of glioblastoma multiforme or GBM....
The researchers at the University of California, Riverside in collaboration with researchers at City of Hope National Medical Center have invented deterministic mechanoporation or DMP - a novel microfluidic device technology to treat cancer....
